Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication
Abstract Aims Recent advances of direct‐acting antiviral drugs for hepatitis C virus (HCV) have dramatically improved the sustained virologic response (SVR) rate, but hepatocellular carcinoma (HCC) development rarely occurs even in patients who achieve an SVR. Wisteria floribunda agglutinin‐positive...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-10-01
|
| Series: | JGH Open |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jgh3.12655 |
| _version_ | 1818650641164140544 |
|---|---|
| author | Shunsuke Sato Hironori Tsuzura Yuji Kita Yuji Ikeda Daishi Kabemura Sho Sato Nozomi Amano Noboru Yatagai Ayato Murata Yuji Shimada Takuya Genda |
| author_facet | Shunsuke Sato Hironori Tsuzura Yuji Kita Yuji Ikeda Daishi Kabemura Sho Sato Nozomi Amano Noboru Yatagai Ayato Murata Yuji Shimada Takuya Genda |
| author_sort | Shunsuke Sato |
| collection | DOAJ |
| description | Abstract Aims Recent advances of direct‐acting antiviral drugs for hepatitis C virus (HCV) have dramatically improved the sustained virologic response (SVR) rate, but hepatocellular carcinoma (HCC) development rarely occurs even in patients who achieve an SVR. Wisteria floribunda agglutinin‐positive mac‐2‐binding protein (WFA+‐M2BP) was recently developed as a noninvasive biomarker of liver fibrosis. However, the association between the WFA+‐M2BP level and HCC development after the achievement of an SVR is unclear. Methods and Results We examined the association between WFA+‐M2BP and HCC development in 522 HCV patients who achieved an SVR (Interferon [IFN]‐based therapy, n = 228; IFN‐free therapy, n = 294). Multivariate analysis revealed that a high WFA+‐M2BP level at SVR week 24 after treatment (SVR24) (hazard ratio [HR] = 1.215, P = 0.020), low platelet counts (HR = 0.876, P = 0.037), and old age (HR = 1.073, P = 0.012) were independent risk factors for HCC development regardless of the treatment regimen. Receiver operator characteristics curve analysis revealed that a WFA+‐M2BP level at SVR24 of ≥1.62 cut‐off index (COI) was the cut‐off value for the prediction of HCC development (adjusted HR = 12.565, 95% CI 3.501–45.092, P < 0.001). The 3‐ and 5‐year cumulative incidences of HCC were 1% and 1.6% in patients with low WFA+‐M2BP at SVR24 (<1.62 COI), and 4.7% and 12.5% in patients with high WFA+‐M2BP (≥1.62 COI) were, respectively (P < 0.001). Conclusions The assessment of liver fibrosis using the WFA+‐M2BP level at SVR24 is a useful predictor of HCC development after HCV eradication even in the IFN‐free therapy era. |
| first_indexed | 2024-12-17T01:53:26Z |
| format | Article |
| id | doaj.art-3c85d0fa3df04e1391f469f4ed4c6b61 |
| institution | Directory Open Access Journal |
| issn | 2397-9070 |
| language | English |
| last_indexed | 2024-12-17T01:53:26Z |
| publishDate | 2021-10-01 |
| publisher | Wiley |
| record_format | Article |
| series | JGH Open |
| spelling | doaj.art-3c85d0fa3df04e1391f469f4ed4c6b612022-12-21T22:08:00ZengWileyJGH Open2397-90702021-10-015101203120910.1002/jgh3.12655Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradicationShunsuke Sato0Hironori Tsuzura1Yuji Kita2Yuji Ikeda3Daishi Kabemura4Sho Sato5Nozomi Amano6Noboru Yatagai7Ayato Murata8Yuji Shimada9Takuya Genda10Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka JapanDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka JapanDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka JapanDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka JapanDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka JapanDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka JapanDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka JapanDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka JapanDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka JapanDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka JapanDepartment of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka JapanAbstract Aims Recent advances of direct‐acting antiviral drugs for hepatitis C virus (HCV) have dramatically improved the sustained virologic response (SVR) rate, but hepatocellular carcinoma (HCC) development rarely occurs even in patients who achieve an SVR. Wisteria floribunda agglutinin‐positive mac‐2‐binding protein (WFA+‐M2BP) was recently developed as a noninvasive biomarker of liver fibrosis. However, the association between the WFA+‐M2BP level and HCC development after the achievement of an SVR is unclear. Methods and Results We examined the association between WFA+‐M2BP and HCC development in 522 HCV patients who achieved an SVR (Interferon [IFN]‐based therapy, n = 228; IFN‐free therapy, n = 294). Multivariate analysis revealed that a high WFA+‐M2BP level at SVR week 24 after treatment (SVR24) (hazard ratio [HR] = 1.215, P = 0.020), low platelet counts (HR = 0.876, P = 0.037), and old age (HR = 1.073, P = 0.012) were independent risk factors for HCC development regardless of the treatment regimen. Receiver operator characteristics curve analysis revealed that a WFA+‐M2BP level at SVR24 of ≥1.62 cut‐off index (COI) was the cut‐off value for the prediction of HCC development (adjusted HR = 12.565, 95% CI 3.501–45.092, P < 0.001). The 3‐ and 5‐year cumulative incidences of HCC were 1% and 1.6% in patients with low WFA+‐M2BP at SVR24 (<1.62 COI), and 4.7% and 12.5% in patients with high WFA+‐M2BP (≥1.62 COI) were, respectively (P < 0.001). Conclusions The assessment of liver fibrosis using the WFA+‐M2BP level at SVR24 is a useful predictor of HCC development after HCV eradication even in the IFN‐free therapy era.https://doi.org/10.1002/jgh3.12655direct‐acting antiviral drughepatitis C virushepatocellular carcinomainterferon‐based therapyinterferon‐free therapysustained virological response |
| spellingShingle | Shunsuke Sato Hironori Tsuzura Yuji Kita Yuji Ikeda Daishi Kabemura Sho Sato Nozomi Amano Noboru Yatagai Ayato Murata Yuji Shimada Takuya Genda Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication JGH Open direct‐acting antiviral drug hepatitis C virus hepatocellular carcinoma interferon‐based therapy interferon‐free therapy sustained virological response |
| title | Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication |
| title_full | Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication |
| title_fullStr | Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication |
| title_full_unstemmed | Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication |
| title_short | Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication |
| title_sort | post treatment serum wisteria floribunda agglutinin positive mac 2 binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis c virus eradication |
| topic | direct‐acting antiviral drug hepatitis C virus hepatocellular carcinoma interferon‐based therapy interferon‐free therapy sustained virological response |
| url | https://doi.org/10.1002/jgh3.12655 |
| work_keys_str_mv | AT shunsukesato posttreatmentserumwisteriafloribundaagglutininpositivemac2bindingproteinlevelisausefulpredictorofhepatocellularcarcinomadevelopmentafterhepatitiscviruseradication AT hironoritsuzura posttreatmentserumwisteriafloribundaagglutininpositivemac2bindingproteinlevelisausefulpredictorofhepatocellularcarcinomadevelopmentafterhepatitiscviruseradication AT yujikita posttreatmentserumwisteriafloribundaagglutininpositivemac2bindingproteinlevelisausefulpredictorofhepatocellularcarcinomadevelopmentafterhepatitiscviruseradication AT yujiikeda posttreatmentserumwisteriafloribundaagglutininpositivemac2bindingproteinlevelisausefulpredictorofhepatocellularcarcinomadevelopmentafterhepatitiscviruseradication AT daishikabemura posttreatmentserumwisteriafloribundaagglutininpositivemac2bindingproteinlevelisausefulpredictorofhepatocellularcarcinomadevelopmentafterhepatitiscviruseradication AT shosato posttreatmentserumwisteriafloribundaagglutininpositivemac2bindingproteinlevelisausefulpredictorofhepatocellularcarcinomadevelopmentafterhepatitiscviruseradication AT nozomiamano posttreatmentserumwisteriafloribundaagglutininpositivemac2bindingproteinlevelisausefulpredictorofhepatocellularcarcinomadevelopmentafterhepatitiscviruseradication AT noboruyatagai posttreatmentserumwisteriafloribundaagglutininpositivemac2bindingproteinlevelisausefulpredictorofhepatocellularcarcinomadevelopmentafterhepatitiscviruseradication AT ayatomurata posttreatmentserumwisteriafloribundaagglutininpositivemac2bindingproteinlevelisausefulpredictorofhepatocellularcarcinomadevelopmentafterhepatitiscviruseradication AT yujishimada posttreatmentserumwisteriafloribundaagglutininpositivemac2bindingproteinlevelisausefulpredictorofhepatocellularcarcinomadevelopmentafterhepatitiscviruseradication AT takuyagenda posttreatmentserumwisteriafloribundaagglutininpositivemac2bindingproteinlevelisausefulpredictorofhepatocellularcarcinomadevelopmentafterhepatitiscviruseradication |